Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00083954
First received: June 3, 2004
Last updated: January 3, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2005
  Estimated Primary Completion Date: No date given